These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16205642)

  • 1. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
    Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
    Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of EphB4 in mesothelioma and its biological significance.
    Xia G; Kumar SR; Masood R; Koss M; Templeman C; Quinn D; Zhu S; Reddy R; Krasnoperov V; Gill PS
    Clin Cancer Res; 2005 Jun; 11(12):4305-15. PubMed ID: 15958611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB4 expression and biological significance in prostate cancer.
    Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
    Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
    Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
    Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphB4 provides survival advantage to squamous cell carcinoma of the head and neck.
    Masood R; Kumar SR; Sinha UK; Crowe DL; Krasnoperov V; Reddy RK; Zozulya S; Singh J; Xia G; Broek D; Schönthal AH; Gill PS
    Int J Cancer; 2006 Sep; 119(6):1236-48. PubMed ID: 16615113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.
    Kumar SR; Singh J; Xia G; Krasnoperov V; Hassanieh L; Ley EJ; Scehnet J; Kumar NG; Hawes D; Press MF; Weaver FA; Gill PS
    Am J Pathol; 2006 Jul; 169(1):279-93. PubMed ID: 16816380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
    Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
    Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
    Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
    Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of normal, paramalignant, and malignant human urothelial cells to inhibitors of the epidermal growth factor receptor signaling pathway.
    MacLaine NJ; Wood MD; Holder JC; Rees RW; Southgate J
    Mol Cancer Res; 2008 Jan; 6(1):53-63. PubMed ID: 18234962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells.
    Chakraborty A; Guha S
    Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPHB4 and survival of colorectal cancer patients.
    Davalos V; Dopeso H; Castaño J; Wilson AJ; Vilardell F; Romero-Gimenez J; Espín E; Armengol M; Capella G; Mariadason JM; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2006 Sep; 66(18):8943-8. PubMed ID: 16982731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion.
    Ding Y; Wang G; Ling MT; Wong YC; Li X; Na Y; Zhang X; Chua CW; Wang X; Xin D
    Int J Oncol; 2006 Apr; 28(4):847-54. PubMed ID: 16525633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
    Blehm KN; Spiess PE; Bondaruk JE; Dujka ME; Villares GJ; Zhao YJ; Bogler O; Aldape KD; Grossman HB; Adam L; McConkey DJ; Czerniak BA; Dinney CP; Bar-Eli M
    Clin Cancer Res; 2006 Aug; 12(15):4671-7. PubMed ID: 16899617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R; Berking C; Kammerbauer C; Degitz K
    Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
    Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
    Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.